Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
- PMID: 25332773
- PMCID: PMC4189340
- DOI: 10.1136/openhrt-2013-000002
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
Abstract
Aim: To gain a better understanding of the impact of chronic obstructive pulmonary disease (COPD) on long-term mortality in patients with myocardial infarction (MI) and identify areas where the clinical care for these patients may be improved.
Methods: Patients hospitalised for MI between 2005 and 2010 were identified from the nationwide Swedish SWEDEHEART registry. Patients with MI and a prior COPD hospital discharge diagnosis were compared to patients with MI without a prior COPD hospital discharge diagnosis for the primary endpoint of all-cause mortality at 1 year after MI. Secondary endpoints included rates of reinfarction, new-onset stroke, new-onset bleeding and new-onset heart failure at 1 year.
Results: A total of 81 191 MI patients were included, of which 4867 (6%) had a COPD hospital discharge diagnosis at baseline. Patients with COPD showed a significantly higher unadjusted 1-year mortality (24.6 vs 13.8%) as well as a higher rate of reinfarction, new-onset bleeding and new-onset heart failure post-MI. After adjustment for potential confounders, including comorbidities and treatment, the patients with COPD still showed a significantly higher 1-year mortality (HR 1.14, 95% CI 1.07 to 1.21) as well as a higher rate of new-onset heart failure (HR 1.35, 95% CI 1.24 to 1.47), whereas no significant association between COPD and myocardial reinfarction or new-onset bleeding remained.
Conclusions: In this nationwide contemporary study, patients with COPD frequently had an atypical presentation, less often underwent revascularisation and less often received guideline-recommended secondary preventive medications of established benefit. Prior COPD was associated with a higher 1-year mortality and a higher risk of subsequent new-onset heart failure after MI. The association seems to be mainly explained by differences in background characteristics, comorbidities and treatment, although a minor part might be explained by COPD in itself. Improved in-hospital MI treatment and post-MI secondary prevention according to the guidelines may lower the mortality in this high-risk population.
Keywords: Coronary Artery Disease; Heart Failure.
Figures
Comment in
-
The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction.Open Heart. 2014 Feb 1;1(1):e000010. doi: 10.1136/openhrt-2013-000010. eCollection 2014. Open Heart. 2014. PMID: 25332777 Free PMC article. No abstract available.
References
-
- WHO. World Health Statistics. 2008. http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf
-
- Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523–32 - PubMed
-
- Lindstrom M, Jonsson E, Larsson K, et al. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2002;6:76–84 - PubMed
-
- Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981–9 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases